hematoxylin has been researched along with Adrenal Cortex Cancer in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bolla, S; Duregon, E; Molinaro, L; Papotti, MG; Righi, L; Sapino, A; Terzolo, M; Ventura, L; Volante, M | 1 |
1 other study(ies) available for hematoxylin and Adrenal Cortex Cancer
Article | Year |
---|---|
Comparative diagnostic and prognostic performances of the hematoxylin-eosin and phospho-histone H3 mitotic count and Ki-67 index in adrenocortical carcinoma.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Aged; Eosine Yellowish-(YS); Female; Hematoxylin; Histones; Humans; Immunohistochemistry; Ki-67 Antigen; Male; Middle Aged; Mitotic Index; Phosphorylation; Prognosis; Survival Rate; Young Adult | 2014 |